首页> 外文期刊>Talanta: The International Journal of Pure and Applied Analytical Chemistry >Magnetic nanoparticles-based lactate dehydrogenase microreactor as a drug discovery tool for rapid screening inhibitors from natural products
【24h】

Magnetic nanoparticles-based lactate dehydrogenase microreactor as a drug discovery tool for rapid screening inhibitors from natural products

机译:基于磁性纳米颗粒的乳酸脱氢酶微反应器作为来自天然产物的快速筛选抑制剂的药物发现工具

获取原文
获取原文并翻译 | 示例
       

摘要

Lactate dehydrogenase (LDH), catalyzing the conversion of pyruvate to lactate during glycolysis, is over-expressed in cancer cells. LDH inhibitors are a promising approach for the treatment of cancer. But up till now, there is limited method for rapid screening of LDH inhibitors. Herein, the use of LDH functionalized magnetic nanoparticles as a drug discovery tool for the selective enrichment of LDH potential inhibitors from natural products was firstly reported in this study. Firstly, LDH was immobilized onto the surface of amino-modified magnetic nanoparticles via covalent binding. In order to obtain the maximum enzyme activity, the immobilization conditions including pH, time and LDH concentration were optimized. The amount of LDH immobilized on MNPs was about 49 pg enzyme/mg carrier under the optimized conditions. Subsequently, the ligand fishing assay was performed to validate the specificity and selectivity of immobilized LDH using a model mixture, which consisted of galloflavin, chlorogenic acid and verbascoside. Finally, the immobilized LDH approach combined with ultra-high performance liquid chromatography-tandem mass spectrometry technique (UHPLC-MS/MS) was applied to screen potential LDH inhibitors from two anthraquinone-rich natural products (Rhubarb and Polygonum cuspidatum). Nine and six compounds were identified from Rhubarb and Polygonum cuspidatum extracts respectively, of which three compounds were common to both. Our results have proven that LDH functionalized magnetic nanoparticles have a significant prospect for drug discovery from complex matrices.
机译:乳酸脱氢酶(LDH),催化丙酮酸在糖酵解期间乳酸乳酸乳酸转化,在癌细胞中过度表达。 LDH抑制剂是治疗癌症的有希望的方法。但到目前为止,LDH抑制剂的快速筛选有限的方法。在此,在本研究中首先在本研究中报道了在本研究中使用LDH官能化磁性纳米粒子作为选择性富集天然产物的LDH潜在抑制剂的药物发现工具。首先,通过共价结合将LDH固定在氨基改性的磁性纳米颗粒的表面上。为了获得最大酶活性,优化了包括pH,时间和LDH浓度的固定条件。在优化条件下,固定在MNP上的LDH的量为约49pg酶/ mg载体。随后,进行配体捕捞测定以使用模型混合物验证固定的LDH的特异性和选择性,所述模型混合物由甘氨苄,绿原酸和血管内组成。最后,将固定化的LDH方法与超高效液相色谱 - 串联质谱技术(UHPLC-MS / MS)相结合,从两种富蒽醌的天然产物(大黄和多糖豆瓣)筛选电位LDH抑制剂。分别从大黄和聚戊糖瘤提取物中鉴定了九和六种化合物,其中三种化合物两者都是共同的。我们的结果证明,LDH官能化磁性纳米粒子对复杂基质的药物发现具有重要前景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号